Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-013864

Chair and CEO sold 25,580 shares at an average $77.03 ($1,970,421)

  • Chair and CEO acquired 25,580 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-17 Exercise or conversion : show line 1 in the form 10b5-1 +18,750 $22.76 $426,750 352,936 D
2025-03-17 Sale : show line 2 in the form 10b5-1 −4,727 $75.91 $358,827 348,209 D
2025-03-17 Sale : show line 3 in the form 10b5-1 −5,907 $76.87 $454,071 342,302 D
2025-03-17 Sale : show line 4 in the form 10b5-1 −8,116 $77.79 $631,344 334,186 D
2025-03-17 Exercise or conversion : show line 5 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-03-17 Sale : show line 6 in the form 10b5-1 −2,023 $76.00 $153,748 238,731 I
2025-03-17 Sale : show line 7 in the form 10b5-1 −2,070 $77.01 $159,411 236,661 I
2025-03-17 Sale : show line 8 in the form 10b5-1 −2,737 $77.83 $213,021 233,924 I
Open-market sales · 25,580 sh · avg $77.03 · $1,970,421

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-17 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −18,750 0 D
2025-03-17 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) −6,830 191,310 I
Loading xslF345X05/wk-form4_1742417573.xml…